Indegene (NSE:INDGN) Total Operating Expense: ₹30,179 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:INDGN Indegene Ltd NSE:INDGN
49 GF Score
Price ₹492.65
! 5 Warning Signs
View Full Analysis

What is Indegene Total Operating Expense?

Indegene NSE:INDGN +0.85% 49 Total Operating Expense is ₹30,179 Mil as of Mar. 2026. GuruFocus rates NSE:INDGN with a GF Score™ of 49/100. The stock has 5 warning signs investors should review.

Indegene's Total Operating Expense for the three months ended in Mar. 2026 was ₹8,816 Mil. Indegene's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹30,179 Mil.

Indegene Total Operating Expense Related Terms

Indegene Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Indegene's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indegene Total Operating Expense Chart

Indegene Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Operating Expense
Get a 7-Day Free Trial 14,106.32 19,698.00 21,548.00 23,852.00 30,127.00

Indegene Quarterly Data
Mar21 Mar22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,288.00 6,271.00 6,870.00 8,222.00 8,816.00
NSE:INDGN
49GF Score
Indegene Ltd NSE:INDGN
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Indegene Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹30,179 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of ₹30,179 Mil mean?
Indegene (NSE:INDGN) has a Total Operating Expense of ₹30,179 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Indegene and its competitors.
Is Indegene's Total Operating Expense too high?
Indegene's current Total Operating Expense is ₹30,179 Mil. Overall, Indegene has a GF Score™ of 49/100, reflecting its overall financial health beyond just this single metric.
How does Indegene's Total Operating Expense compare to VEEV and BTSG?
Indegene's Total Operating Expense of ₹30,179 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Healthcare Providers & Services company?
A good Total Operating Expense depends on the Healthcare Providers & Services industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Indegene and its competitors. Indegene's current Total Operating Expense is ₹30,179 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indegene stock overvalued right now?
Indegene (NSE:INDGN) has a current Total Operating Expense of ₹30,179 Mil. The current Total Operating Expense is ₹30,179 Mil. Indegene's overall GF Score™ is 49/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Indegene (NSE:INDGN), the current Total Operating Expense is ₹30,179 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Indegene Business Description

Other Exchanges 544172:India
Address Outer Ring Road, Aspen Block G4, 3rd Floor, Manyata Embassy Business Park, Nagawara, Bengaluru, KA, IND, 560045
Indegene Ltd provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical device companies. It assists them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. Its portfolio of solutions covers all aspects of commercial, medical, regulatory, and R&D operations for life sciences companies. The company's segments include Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation, and Others. Key revenue is generated from the Omnichannel Activation segment. The company has a presence in India, Europe, and North America, with the majority of revenue coming from North America.
49GF Score

Get the complete analysis for NSE:INDGN

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹492.65
Price